300 related articles for article (PubMed ID: 29617672)
21. Circulating microparticles in systemic Lupus Erythematosus.
Nielsen CT
Dan Med J; 2012 Nov; 59(11):B4548. PubMed ID: 23171755
[TBL] [Abstract][Full Text] [Related]
22. Sources of autoantigens in systemic lupus erythematosus.
Graham KL; Utz PJ
Curr Opin Rheumatol; 2005 Sep; 17(5):513-7. PubMed ID: 16093826
[TBL] [Abstract][Full Text] [Related]
23. ADAR1 and MicroRNA; A Hidden Crosstalk in Cancer.
Cho CJ; Myung SJ; Chang S
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398248
[TBL] [Abstract][Full Text] [Related]
24. Genetic knock out of 60kD Ro (or SSA), a common lupus autoantigen, induces lupus.
Scofield RH
Trends Immunol; 2004 Jan; 25(1):1-3. PubMed ID: 14698275
[TBL] [Abstract][Full Text] [Related]
25. Alternative exon usage in TRIM21 determines the antigenicity of Ro52/TRIM21 in systemic lupus erythematosus.
Gomez-Bañuelos E; Wahadat MJ; Li J; Paz M; Antiochos B; Celia AI; Andrade V; Ferris DP; Goldman DW; Darrah E; Petri M; Andrade F
JCI Insight; 2022 Oct; 7(19):. PubMed ID: 36040804
[TBL] [Abstract][Full Text] [Related]
26. Nucleosomes in the pathogenesis of systemic lupus erythematosus.
Koutouzov S; Jeronimo AL; Campos H; Amoura Z
Rheum Dis Clin North Am; 2004 Aug; 30(3):529-58, ix. PubMed ID: 15261340
[TBL] [Abstract][Full Text] [Related]
27. Diverse functions for DNA and RNA editing in the immune system.
Hamilton CE; Papavasiliou FN; Rosenberg BR
RNA Biol; 2010; 7(2):220-8. PubMed ID: 20220309
[TBL] [Abstract][Full Text] [Related]
28. Adenosine Deaminases That Act on RNA (ADARs).
Wang Y; Zheng Y; Beal PA
Enzymes; 2017; 41():215-268. PubMed ID: 28601223
[TBL] [Abstract][Full Text] [Related]
29. Do naturally occurring autoantibodies participate in the constitution of the pathological B-cell repertoire in systemic lupus erythematosus?
Gilbert D; Brard F; Jovelin F; Tron F
J Autoimmun; 1996 Apr; 9(2):247-57. PubMed ID: 8738970
[TBL] [Abstract][Full Text] [Related]
30. Antibody against chromatin assembly factor-1 is a novel autoantibody specifically recognized in systemic lupus erythematosus.
Doe K; Nozawa K; Hiruma K; Yamada Y; Matsuki Y; Nakano S; Ogasawara M; Nakano H; Ikeda T; Ikegami T; Fujishiro M; Kawasaki M; Ikeda K; Amano H; Morimoto S; Ogawa H; Takamori K; Sekigawa I; Takasaki Y
Lupus; 2014 Sep; 23(10):1031-41. PubMed ID: 24836587
[TBL] [Abstract][Full Text] [Related]
31. ADAR RNA editing in human disease; more to it than meets the I.
Gallo A; Vukic D; Michalík D; O'Connell MA; Keegan LP
Hum Genet; 2017 Sep; 136(9):1265-1278. PubMed ID: 28913566
[TBL] [Abstract][Full Text] [Related]
32. SS-56, a novel cellular target of autoantibody responses in Sjögren syndrome and systemic lupus erythematosus.
Billaut-Mulot O; Cocude C; Kolesnitchenko V; Truong MJ; Chan EK; Hachula E; de la Tribonnière X; Capron A; Bahr GM
J Clin Invest; 2001 Sep; 108(6):861-9. PubMed ID: 11560955
[TBL] [Abstract][Full Text] [Related]
33. New Insights into the Biological Role of Mammalian ADARs; the RNA Editing Proteins.
Mannion N; Arieti F; Gallo A; Keegan LP; O'Connell MA
Biomolecules; 2015 Sep; 5(4):2338-62. PubMed ID: 26437436
[TBL] [Abstract][Full Text] [Related]
34. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
Ganem NS; Ben-Asher N; Lamm AT
Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
[TBL] [Abstract][Full Text] [Related]
35. A cytosine deaminase for programmable single-base RNA editing.
Abudayyeh OO; Gootenberg JS; Franklin B; Koob J; Kellner MJ; Ladha A; Joung J; Kirchgatterer P; Cox DBT; Zhang F
Science; 2019 Jul; 365(6451):382-386. PubMed ID: 31296651
[TBL] [Abstract][Full Text] [Related]
36. A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients.
Yaniv G; Twig G; Shor DB; Furer A; Sherer Y; Mozes O; Komisar O; Slonimsky E; Klang E; Lotan E; Welt M; Marai I; Shina A; Amital H; Shoenfeld Y
Autoimmun Rev; 2015 Jan; 14(1):75-9. PubMed ID: 25449682
[TBL] [Abstract][Full Text] [Related]
37. Identification of candidate endothelial cell autoantigens in systemic lupus erythematosus using a molecular cloning strategy: a role for ribosomal P protein P0 as an endothelial cell autoantigen.
Frampton G; Moriya S; Pearson JD; Isenberg DA; Ward FJ; Smith TA; Panayiotou A; Staines NA; Murphy JJ
Rheumatology (Oxford); 2000 Oct; 39(10):1114-20. PubMed ID: 11035132
[TBL] [Abstract][Full Text] [Related]
38. An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer.
Qi L; Song Y; Chan THM; Yang H; Lin CH; Tay DJT; Hong H; Tang SJ; Tan KT; Huang XX; Lin JS; Ng VHE; Maury JJP; Tenen DG; Chen L
Nucleic Acids Res; 2017 Oct; 45(18):10436-10451. PubMed ID: 28985428
[TBL] [Abstract][Full Text] [Related]
39. Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma.
Oakes E; Anderson A; Cohen-Gadol A; Hundley HA
J Biol Chem; 2017 Mar; 292(10):4326-4335. PubMed ID: 28167531
[TBL] [Abstract][Full Text] [Related]
40. ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer.
Chan TH; Qamra A; Tan KT; Guo J; Yang H; Qi L; Lin JS; Ng VH; Song Y; Hong H; Tay ST; Liu Y; Lee J; Rha SY; Zhu F; So JB; Teh BT; Yeoh KG; Rozen S; Tenen DG; Tan P; Chen L
Gastroenterology; 2016 Oct; 151(4):637-650.e10. PubMed ID: 27373511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
